Filings/MAB/IR

MABION S.A. IR

press release ยท 2026

Mabion is back โ€“ reactivation of the MabionCD20 project opens the way to commercializing the drug in the orphan diseases area 08.05.2026 Learn more

Source document

Issuer site
Loading documentโ€ฆ
Mabion is back โ€“ reactivation of the MabionCD20 project opens the way to commercializing the drug in the orphan diseases area 08.05.2026 Learn more โ€” MABION S.A.